|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/18 | (2006.01) |
| A61K 31/427 | (2013.01) | ||
| A61K 31/407 | (2006.01) | ||
| A61K 31/431 | (2013.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61K 31/546 | (2013.01) | ||
| A61K 31/551 | (2013.01) | ||
| A61K 31/427 | (2006.01) | ||
| A61K 31/431 | (2006.01) | ||
| A61K 31/407 | (2013.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/4545 | (2013.01) | ||
| A61K 31/546 | (2006.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61K 31/551 | (2006.01) | ||
| C07D 471/18 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| Y02A 50/30 | (2018.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61K 31/5025 | (2013.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Patento numeris | 3698796 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20165564.4 |
| Europos patento paraiškos padavimo data | 2017-09-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-08-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-10-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201662401022 P | 2016-09-28 | US |
| (72) |
CASAREZ, Anthony , US
FUREGATI, Markus , CH
KOCH, Guido , CH
LIN, Xiaodong , US
OSSOLA, Flavio , CH
RECK, Folkert , US
SIMMONS, Robert Lowell , US
ZHU, Qingming , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS |
| PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS |